Immunomic Therapeutics Licenses Investigational Canine Dermatitis Therapy to ZENOAQ
ROCKVILLE, Md.--(BUSINESS WIRE)--Feb 6, 2019--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company has grant…
